+1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Mini ReviewOpen Access

Trends in Pharmacogenetics

Volume 11 - Issue 2

Shweta S Joshi and Husayn Ahmed P*

  • Author Information Open or Close
    • National Centre for Biological Sciences, India
    • *Corresponding author: Husayn Ahmed P, National Centre for Biological Sciences, India

Received: November 16, 2018;   Published: November 21, 2018

DOI: 10.26717/BJSTR.2018.11.002073

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Since the initial studies in the 1950s, the field of pharmacogenetics has shown a lot of promise. The advent of high-throughput technology and next-generation sequencing has only added to the development of this field. Amidst several challenges like the lack of a comprehensive genomic database and varied prescription practices, pharmacogenetics has immense potential from the personalized medicine, novel biomarker discovery and drug development perspective in a genetically diverse population like India.

Keywords : EMEA: European Agency For Evaluation of Medicinal Products, ADRS: Adverse Drug Reactions, PD: Pharmacodynamics, PK: Pharmacokinetics, CPIC: Clinical Pharmacogenetics Implementation Consortium

Introduction| Pharmacogenetics in a Nutshell and its History| Need for Pharmacogenetics in the Indian Context| Potential Applications and Challenges| Conclusion References|